Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis

Giovanni Cioffi1, Dana Cramariuc, Morten Dalsgaard

  • 1Department of Cardiology, Villa Bianca Hospital, Trento, Italy. gcioffi@villabiancatrento.it

Insights

Higher left atrial systolic force (LASF) indicates a higher risk of cardiovascular events in patients with aortic valve stenosis (AS). This finding helps identify high-risk individuals for better management of AS.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Clinical Research

Background:

  • Chronic pressure overload in hypertension or aortic valve stenosis (AS) is linked to a high-risk cardiovascular (CV) phenotype.
  • Higher left atrial systolic force (LASF) is a recognized indicator of this high-risk CV phenotype.

Purpose of the Study:

  • To evaluate the prognostic value of LASF in patients diagnosed with AS.
  • To determine if LASF can predict major adverse cardiovascular events in individuals with AS.

Main Methods:

  • Analysis of baseline and outcome data from 1,566 patients in the Simvastatin and Ezetimibe in AS (SEAS) study.
  • LASF was calculated using Manning's method, with high LASF defined as exceeding the 95th percentile (>50 Kdynes/cm(2)).
  • Primary outcome was a composite of major CV events, analyzed via multivariate Cox regression.

Main Results:

  • Patients with high LASF experienced a higher rate of major CV events (49%) compared to those with normal LASF (34%) (P = 0.01).
  • High LASF independently predicted an increased rate of major CV events (Hazard ratio 1.43), irrespective of aortic valve area and LV mass index.
  • A risk score incorporating LASF stratified patients into distinct risk categories for CV events.

Conclusions:

  • Elevated LASF provides significant additional prognostic information in patients with asymptomatic, mild-to-moderate AS.
  • LASF can aid in identifying patients at higher risk for adverse cardiovascular outcomes.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...